Back
Nephros, Inc. 10K Form
Buy
69
NEPH
Nephros, Inc.
Last Price:
$5.58
Seasonality Move:
-4.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-02-27 | 10K | NEPH/Nephros, Inc. Annual |
| 2019-11-06 | 10Q | NEPH/Nephros, Inc. Quarterly |
| 2019-08-07 | 10Q | NEPH/Nephros, Inc. Quarterly |
| 2019-05-08 | 10Q | NEPH/Nephros, Inc. Quarterly |
| 2019-03-12 | 10K | NEPH/Nephros, Inc. Annual |
| 2018-11-08 | 10Q | NEPH/Nephros, Inc. Quarterly |
Receive NEPH News And Ratings
See the #1 stock for the next 7 days that we like better than NEPH
NEPH Financial Statistics
Sales & Book Value
| Annual Sales: | $14.2M |
|---|---|
| Cash Flow: | $99K |
| Price / Cash Flow: | 22.35 |
| Annual Sales: | $0.94 |
| Price / Book: | 6 |
Profitability
| EPS (TTM): | 0.13810 |
|---|---|
| Net Income (TTM): | $1.5M |
| Gross Margin: | $8.6M |
| Return on Equity: | 16.22% |
| Return on Assets: | 12.58% |
Nephros, Inc. Earnings Forecast
Key Nephros, Inc. Financial Ratios
-
The Gross Profit Margin over the past 25 years for NEPH is 60.64%.
-
The Selling, General & Administrative Expenses for NEPH have been equal to 54.20% of Gross Profit Margin.
-
The Research & Development expenses have been 6.40% of Revenue.
-
The Interest Expense is 1.35% of Operating Income.
-
The Net Earning history of NEPH is 0.52% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 14 years.
Nephros, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Machinery |
| Sector: | Industrials |
| Current Symbol: | NEPH |
| CUSIP: | 640671 |
| Website: | nephros.com |
Debt
| Debt-to-Equity Ratio: | 0.12 |
|---|---|
| Current Ratio: | 4.34 |
| Quick Ratio: | 3.17 |
Price-to-Earnings
| Trailing P/E Ratio: | 807.14 |
|---|---|
| Forward P/E Ratio: | 37.67 |
NEPH Technical Analysis vs Fundamental Analysis
Buy
69
Nephros, Inc. (NEPH)
is a Buy
Is Nephros, Inc. a Buy or a Sell?
-
Nephros, Inc. stock is rated a BuyThe current Nephros, Inc. [NEPH] share price is $5.65. The Score for NEPH is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.